Mystic, CT, United States of America

Bryson Rast

This inventor holds 5 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 2004-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bryson Rast. Retrieved from https://idiyas.com/inventor/bryson-rast-covkzhed

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2005

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Bryson Rast: Innovator in Anti-Inflammatory Agents

Introduction

Bryson Rast is a notable inventor based in Mystic, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and analgesic agents. With a total of 5 patents to his name, Rast's work is paving the way for new treatments for various inflammatory disorders.

Latest Patents

Rast's latest patents include innovative compounds such as heterocyclo-alkylsulfonyl pyrazoles and sulfonyl heteroaryl triazoles. These compounds are designed to treat inflammation and associated disorders, including osteoarthritis, rheumatoid arthritis, colon cancer, and Alzheimer's disease. The pharmaceutical compositions containing these compounds are intended for use in mammals, particularly humans, dogs, cats, and livestock.

Career Highlights

Bryson Rast is currently employed at Pfizer Corporation, where he continues to advance his research in pharmaceutical innovations. His work focuses on creating effective treatments that address significant health challenges faced by many individuals today.

Collaborations

Rast collaborates with talented colleagues, including Subas Man Sakya and Andrei Shavnya, who contribute to the innovative environment at Pfizer Corporation.

Conclusion

Bryson Rast's contributions to the field of anti-inflammatory agents highlight his dedication to improving health outcomes through innovation. His ongoing work promises to make a lasting impact on the treatment of inflammatory disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…